{"disease":{"id":"ctd-ild","name":"ctd ild"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06644144","title":"P4O2 ILD Extension","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT07495033","title":"Phase III Clinical Trial of Telitacicept Injection in the Treatment of Patients With Connective Tissue Disease-related Interstitial Lung Disease","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":260,"lead_sponsor_name":"RemeGen Co., Ltd.","has_results":false},{"nct_id":"NCT06823063","title":"Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-P) in the Treatment of CTD-ILD","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":18,"lead_sponsor_name":"Shanghai IxCell Biotechnology Co., LTD","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}